NextCure, Inc. · NASDAQ:NXTC
Affinity Asset Advisors, LLC reported a 9.99% stake in NextCure, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 13, 2026
Affinity Asset Advisors, LLC reported a 9.99% stake in NextCure, Inc., 475,626 shares, as a passive investor on Sep 30, 2026. Filed Nov 13, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 475,626
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Affinity Asset Advisors, LLC | 9.99% | 475,626 |
| Michael Cho | 9.99% | 475,626 |
Source
Download original · View original at SEC
Related
- NextCure, Inc.
- Affinity Asset Advisors, LLC
- NextCure, Inc. shareholders
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Jan 29, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Nov 14, 2025
- Schedule 13G/A · Ikarian Capital, LLC · Nov 16, 2026
- Form 4 · ADAR1 Capital Management, LLC · Nov 13, 2026
- Form 4 · ADAR1 Capital Management, LLC · Nov 9, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 27, 2026
- Schedule 13G · JP Sailing Capital Ltd · Oct 20, 2026